A Study to Compare Two Bioanalytical Assays for Tebipenem

计划入组 20 人 · 首次发布于 2023 年 5 月 12 日

DEFLECT I: Keystone Heart Embolic Deflection Trial

计划入组 37 人 · 首次发布于 2011 年 10 月 7 日

Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)

计划入组 342 人 · 首次发布于 2021 年 3 月 19 日

Ceramide NanoLiposome(Keystone Nano, Inc.)

Ketone Rx (Juvenescence)

PDE4 inhibitor (Reistone Biopharma)

KEYSTONE HEART LTD

Israel

Keystone Nano, Inc.

United States

Crozer-Keystone Health System

United States

SGS Acquires Keystone Bioanalytical to Expand North American Drug Development Testing Capabilities

U.S. Cell and Gene Therapy Bioanalytical Testing Market to Reach $349 Million by 2034

Onco-Innovations Advances PNKP Inhibitor Toward Clinical Trials with Nucro-Technics Bioanalytical Partnership